#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Undifferentiated sarcoma Acquired C1 inhibitor deficiency Rhabdoid tumour Cardiac sarcoidosis High-grade B-cell lymphoma Selective polysaccharide antibody deficiency Pseudoxanthoma elasticum Paraneoplastic neurological syndrome Pneumonia Bronchiolitis Pulmonary arterial hypertension Hypocalcaemia Short-bowel syndrome Stiff person syndrome Biotinidase deficiency More trials…

    Learn about Rare Diseases

    Toxic epidermal necrolysis – Basic Information Paroxysmal nocturnal haemoglobinuria – Trials in Disease Angiosarcoma non-metastatic – Basic Information Antisynthetase syndrome CADASIL – Trials in Disease Systemic mastocytosis – Basic Information Mucopolysaccharidosis I – Treatment Langerhans cell sarcoma Focal segmental glomerulosclerosis – Basic Information Pelizaeus-Merzbacher disease – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Eo2317 Osimertinib Litenimod Sodium Clopidogrel Hydrogen Sulfate Pevonedistat Int-787 Berzosertib Cloxacillin Sodium Recombinant Interferon Beta-1B Sodium Sulfate Anhydrous HUMAN COAGULATION FACTOR XIII Tuvusertib Calcium Chloride Hexahydrate Benzylpenicillin Neratinib GRNA1599 Xtmab-16 Ly3473329 Insulin Aspart Tulmimetostat More therapies…

    Learn about Your Condition

    Menopause Follicular lymphoma stage III Anaemia of pregnancy Rhinitis allergic Coma Sinus rhythm Glomerulonephritis Asymptomatic HIV infection Hepatotoxicity Lupus nephritis Acne Ovarian cancer stage IV Aortic disorder Colorectal cancer stage III Alport's syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study of anifrolumab effectiveness compared to placebo in adults aged 18-70 with systemic sclerosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Anifrolumab
    Austria Belgium France Germany Hungary Italy +4

  • Study of GS-5718 for Patients with Cutaneous Lupus Erythematosus (CLE)

    Not recruiting

    2 1
    Investigated Diseases:
    • Cutaneous lupus erythematosus
    Investigated Drugs:
    • Gs-5718-03
    Czechia Germany Spain

  • Study on the Effects of Romosozumab and Bisphosphonates in Children and Adolescents with Osteogenesis Imperfecta

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteogenesis imperfecta
    Investigated Drugs:
    • Calcium
    • Ergocalciferol
    • Romosozumab
    Austria Belgium France Germany Hungary Italy +3

  • Study of PF-06823859 for Adults with Active Cutaneous or Systemic Lupus Erythematosus with Skin Symptoms

    Not recruiting

    2 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    • Cutaneous lupus erythematosus
    Investigated Drugs:
    • Humanised Igg1K Monoclonal Antibody Against Interferon Beta
    Greece Spain

  • Study on Upadacitinib for Adults and Adolescents with Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure

    Not recruiting

    3 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Upadacitinib
    Austria Belgium Bulgaria Croatia Czechia Finland +12

  • Study on Spesolimab for Treating Recurrent Flares in Patients with Generalized Pustular Psoriasis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Spesolimab
    Belgium France Germany Italy Spain
Previous Page
1 … 52 53 54 55 56 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!